Evidence of Urtica dioica Agglutininʼs Antiproliferative and Anti-migratory Potentials on the Hyaluronic Acid-Overexpressing Prostate Cancer Cells
Planta Medica · 01.08.2024 · 90 (10) · 774-784
DOI: 10.1055/a-2324-2250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.08.2024. Verfasst von Mohammadkazem Heydari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, Faculty of Science, University of Mazandaran, Babolsar, Mazandaran, Iran. Hauptthemen laut MEDLINE: Hyaluronic Acid, Prostatic Neoplasms, Cell Movement, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: University of Mazandaran.
Abstract (Originalsprache)
Hyaluronic acid is composed of repeating sugar units, glucuronic acid and N-acetylglucosamine, which are often associated with increased tumor progression. Urtica dioica agglutinin is a potential component that exhibits a high affinity for binding to N-acetylglucosamine. This study aimed to investigate U. dioica Agglutininʼs potential to inhibit the proliferation and migration of prostate cancer cells with high expression of hyaluronic acid through molecular docking and in vitro studies. The expression of hyaluronan synthase genes in prostate tissue and cell lines was checked by an in silico study, and the interaction between hyaluronic acid with both CD44 transmembrane glycoprotein and U. dioica agglutinin was analyzed through molecular docking. U. dioica Agglutininʼs effect on cell viability (neutral red uptake assay), migration (scratch wound healing assays), and both CD44 and Nanog expression (quantitative real-time polymerase chain reaction) were assessed in vitro. The results showed that in prostate cancer cell lines, the PC3 cell line has the highest expression of hyaluronan synthase genes. U. dioica agglutinin exhibits an interaction of six specific residues on CD44 compared to hyaluronic acidʼs singular residue. While U. dioica agglutinin alone effectively reduced cell viability and wound closer (≥ 150 µg/mL), combining it with hyaluronic acid significantly shifted the effective concentration to a higher dose (≥ 350 µg/mL). These results, together with low Nanog and high CD44 gene expression, suggest that U. dioica agglutinin may impair the CD44-HA pathway in PC3 cells. This possibility is supported by U. dioica Agglutininʼs ability to compete with hyaluronic acid for binding to CD44. Based on this, U. dioica agglutinin as a plant lectin shows promise in inhibiting cancer proliferation and migration by targeting its dependence on hyaluronic acid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cell Biology, Faculty of Science, University of Mazandaran, Babolsar, Mazandaran, Iran.
- Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Tehran, Iran.
- Department of Cancer Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Babol, Iran.
ORCID-Profile: Abasalt Hosseinzadeh Colagar
Förderung
- University of Mazandaran
Zitieren
APA
Heydari, M., Hosseinzadeh Colagar, A., Sabour, D., & Khorasani, H. R. (2024). Evidence of Urtica dioica Agglutininʼs Antiproliferative and Anti-migratory Potentials on the Hyaluronic Acid-Overexpressing Prostate Cancer Cells. Planta Medica, 90(10), 774-784. https://doi.org/10.1055/a-2324-2250
Vancouver
Heydari M, Hosseinzadeh Colagar A, Sabour D, Khorasani HR. Evidence of Urtica dioica Agglutininʼs Antiproliferative and Anti-migratory Potentials on the Hyaluronic Acid-Overexpressing Prostate Cancer Cells. Planta Medica. 2024;90(10):774-784. doi:10.1055/a-2324-2250
BibTeX
@article{Heydari2024,
author = {Heydari, Mohammadkazem and Hosseinzadeh Colagar, Abasalt and Sabour, Davood and Khorasani, Hamid Reza},
title = {Evidence of Urtica dioica Agglutininʼs Antiproliferative and Anti-migratory Potentials on the Hyaluronic Acid-Overexpressing Prostate Cancer Cells},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {10},
pages = {774--784},
doi = {10.1055/a-2324-2250}
}
EUVIMED